Conference Coverage: ASCO and EHA 2024 – Focus on Lymphoma
Lymphoma-specific discussions on therapeutic advances and their application in clinical decision-making
June 20, 2024
Faculty Chair
Brad S. Kahl, MD
Washington University School of Medicine, St Louis, MO, USA
Faculty Members
Matthew Lunning, DO, FACP
University of Nebraska Medical Center, Omaha, NE, USA
Paolo Caimi, MD
Cleveland Clinic, Cleveland, OH, USA
P. Connor Johnson, MD
Massachusetts General Hospital, Boston, MA, USA
John Gribben, MD
Barts Cancer Institute, London, UK
Georg Hess, MD
Johannes Gutenberg University, Mainz, Germany
Pier Luigi Zinzani, MD, PhD
University of Bologna, Italy
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Advances in DLBCL/Aggressive B-Cell Lymphoma Excluding CAR T
- Advances in CAR T for NHL/CLL – Clinical Updates
- Advances in CAR T for NHL/CLL – Special Questions
- Advances in MCL
- Advances in FL and MZL
- Evolving Therapies in CLL/SLL
